Muscle Repair
Muscle tears, DOMS, and overtraining syndrome require more than rest days. Peptide therapy delivers tissue-level solutions — activating satellite cells, modulating inflammation, and optimizing growth-hormone pathways for accelerated repair.
Check Your Eligibility →Muscle tissue is designed to repair itself, but the process depends on a cascade of biological signals — inflammation control, satellite cell activation, growth factor release, and protein synthesis. When training volume exceeds recovery capacity, or when injuries disrupt the repair cycle, the body falls behind.
Peptide therapy targets the specific bottlenecks in muscle repair. BPC-157 accelerates healing at the myotendinous junction where tears occur most frequently. Ipamorelin stimulates growth hormone release, which drives IGF-1 production and satellite cell activation. CJC-1295 extends the GH pulse for sustained anabolic signaling throughout the recovery window.
Three peptides targeting different phases of the muscle-repair cycle.
Targets the myotendinous junction — the area where muscle meets tendon and where tears most commonly occur — accelerating local tissue repair.
Selective GH secretagogue that stimulates natural growth hormone release, driving IGF-1 production and satellite cell activation for muscle repair.
GHRH analogue that extends the growth hormone pulse when paired with Ipamorelin, sustaining anabolic signaling throughout the recovery window.
Complete a brief online health questionnaire. Our medical team reviews your history, goals, and current medications to determine eligibility.
A licensed physician reviews your intake and prescribes a personalized peptide protocol. Your prescription is sent to a licensed 503a/503b compounding pharmacy.
Your peptides are compounded fresh, packed discreetly, and shipped directly to your door — typically within 48 hours of pharmacy processing.
Most patients report noticeable improvement within 2–4 weeks of starting a muscle-repair peptide protocol. The severity of the tear, your age, and overall health all influence the timeline. Minor strains may respond faster, while more significant tears typically require a full 6–8 week protocol. Your prescribing physician will set realistic expectations based on your specific situation.
In most cases, yes — with appropriate modifications. Peptide therapy supports recovery but does not eliminate the need for smart programming. Your physician may recommend reducing intensity or volume during the initial healing phase, then gradually increasing load as tissue repair progresses. Many athletes find they can return to full training faster with peptide support than with rest alone.
Ipamorelin stimulates your body's own pituitary gland to release growth hormone in a natural, pulsatile pattern. This is fundamentally different from injecting exogenous GH, which bypasses the body's feedback mechanisms and carries a higher risk of side effects. Ipamorelin is selective — it does not significantly raise cortisol or prolactin — and preserves the body's natural GH regulation. This makes it safer for long-term use under physician supervision.
Many patients report reduced severity and duration of delayed-onset muscle soreness (DOMS) while on peptide protocols. BPC-157's anti-inflammatory properties and Ipamorelin's GH-mediated recovery support both contribute to faster resolution of exercise-induced muscle damage. This allows for higher training frequency and volume over time.
BPC-157 and Ipamorelin/CJC-1295 have established safety profiles when prescribed at therapeutic doses and compounded at licensed pharmacies. Protocols are typically run in 6–12 week cycles with periodic breaks, as recommended by your physician. Ongoing monitoring ensures the protocol remains safe and effective for your individual needs. Your physician will adjust dosing or cycle length based on your response and bloodwork.
A physician is ready to evaluate your eligibility for muscle-repair peptide therapy — at no cost to start.
Check Your Eligibility →